Home > Boards > US OTC > Medical - Healthcare >

AVVAA World Health Care Products (AVVH)

Add AVVH Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/11/2019 11:03:19 PM - Followers: 91 - Board type: Free - Posts Today: 0

avVaa World Health Care Products


New Website for Neuroskin products: http://www.neuroskin.com/

Visit Neuroskin on FACEBOOK

AVVH is fully compliant and up to date with the SEC.                                                               >>>   685,024,000  Restricted shares plus the BCSC CTO in Canada have half the float tied up.   <<<


2014/05/16  http://www.marketwatch.com/story/resignation-of-AVVH director-and-officer-Jason Price

2014/03/28 Avvaa anounces the addition of 2 new products to its Neuroskin brand

2014-03-18  Consolidated Financial Statement   >>>>>SALES UP OVER 600 %<<<<<

2014/11/18  Marketwatch.com- Walgreens distribution agreement

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=111888   2013/10/14  Interim Financial Report (>>>>>sales UP<<<<<)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=111822   2013/10/09  Supplemental Information concerning Annual OTC Disclosure
http://finance.yahoo.com/news/avvaa-signs-distribution-agreement-natural-130000479.html 2013/10/21 NEUROSKIN products now carried byVP Plus Marketing

http://www.otcmarkets.com/stock/AVVH/news?id=69674  2013/10/10 AVVAA Files Form with BCSC to Cease Being a Reporting Company in British Columbia in order to have BCSC CTO removed

http://www2.thestockmarketwatch.com/newsletters-2013/09/17 NEUROSKIN products offered on Yeswellness.com

http://online.wsj.com/article/PR-CO-20130819-908249.html  Interview with the new CEO Jason Price

  2013/08/12 AVVH successfully negotiates the rights to the trademark 'Neuroskin'

http://www.marketwatch.com/story/avvaa-world-health-care-products-announces-major-sales-contracts-2013-08-05 Sales contract with Petonic Pet Supply and Atlantic Co-Op Country store chain

http://www.marketwatch.com/story/avvaa-updates-financials-promoted-to-otc-pink-current-information-2013-05-01 AVVH promoted to OTC current status

Chairman & CEO:                                                          Transfer Agent:
  Jason S. Price                                                              Signature Stock Transfer Company,
  P: 1-866-864-6598                                                         2632 Coachlight Court Plano TX 75093
  Email: jason.price@avvaa.com                                        Telephone: 972.612.4120

Corporate Office:                                                           A/S: 4,000,000,000
7400 Beaufont Springs Dr.                                                  O/S: 1,882,828,559  7/29/2013                                        
Suite 300                                                                           
Richmond, VA. 23225                                                          At least 685,024,000 of the O/S are restricted by SEC rule 144 http://www.mofo.com/files/Uploads/Documents/FAQRule144_145.pdf
Telephone: 1.866.864.6598                                                                             plus there is currently a CTO for Canadian shareholders

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that

improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and

were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is

marketing it's Neuroskin line of skin care products through mass food and drug channels such as Walgreens in the United States and globally. The Company's

secondary line of equine and pet care related products are already being distributed by the Atlantic Co-Op Country Store chain throughout all of Canada. For more information, visit: www.neuroskin.com

About the NEUROSKIN®  line of skin care products:

For online purchases, go to http://www.neuroskin.com/

NEUROSKIN offers products for psoriasis relief, mild skin conditions, acne treatment and itch relief. Neuroskin products are tested and FDA compliant and DIN approved as over-the-counter pharmaceuticals as well as cosmetic skin care products. They are available over-the-counter and are extremely easy to use, non-toxic products, having no side effects on the human body or the environment. The products do not contain unnatural ingredients such as cortisone, antibiotics and alcohol. The formula is non-greasy, odorless and does not stain clothing, unlike other creams and ointments. Patients have reported noticeable reduction of symptoms after just the first application. NEUROSKIN will replace prescription medication for patients, using expensive therapies and steroids. NEUROSKIN fits with the attitude of the century, which is to go more natural and avoid potentially toxic substances.

There is presently no cure for psoriasis and eczema, skin diseases which are chronic and require continuous therapy. Patients are required to seek out products that can relieve and treat the symptoms of itching and redness caused by these skin irritations. Tests in Germany have proven the product to be effective on 995 out of 1000 people (99.5%). The tests indicated and proved NEUROSKIN did not cause any side effects. Unlike many competitors, NEUROSKIN does not contain cortisone, antibiotics, alcohol, steroids or other unnatural ingredients or additives. The formula is non-greasy and odorless, does not stain clothing, and is easy to use.

NEUROSKIN Psoriasis Relief is a patented, steroid-free, all natural therapeutic skin care product containing minerals and oils in a non-greasy fast drying formula that cools and sooths irritated skin. The product reduces inflammation, redness and itching and it promotes healing and repair of damaged skin, enhancing its natural texture. NEUROSKIN Psoriasis Relief treats the symptoms of psoriasis as well as eczema, dermatitis and other minor skin irritations. This product is FDA-compliant and DIN approved as an over-the-counter OTC product. avVaa owns the blow-molds for the unique 50 ml bottle which was developed using focus groups from the medical fields.

NEUROSKIN Mild Skin Moisturizer is a natural cosmetic for those with sensitive skin (elderly and babies) NEUROSKIN Mild Skin Moisturizer has had early success in the treatment of radiation and thermal burns. Dr. Alden will be working closely with this product in clinical trials for the specific treatment of burns.

NEUROSKIN Acne Treatment is a cosmetic skin care product, which clears up acne, promoting blood circulation on the affected parts of the skin. Within a few days the inflamed "blackhead" pores open, their contents expel, and then proceed to dry up. This product is FDA-compliant and DIN approved as and over-the-counter OTC product.

NEUROSKIN Itch Relief is a steroid-free, all natural topical analgesic lotion, which relieves the discomfort and stops the itch caused by insect bites, allergies, shingles, minor cuts and other minor skin irritations. This product is FDA-compliant and DIN approved as an over-the-counter OTC product.

Disease Descriptions

Psoriasis is a chronic skin disease marked by periodic flare-ups of sharply defined red patches covered by a silvery, flaky surface.

Eczema (atopic dermatitis) is an allergic skin condition that causes itching, sometimes to an intense degree. Over time, the lesions tend to scale and flake. If bacterial or viral infection is introduced by scratching, the affected lesions will ooze.

Acne is a disorder of the skin's oil glands that results in plugged pores and outbreaks of lesions commonly called pimples or zits. Acne lesions usually occur on the face, neck, back, chest and shoulders.

With the successful transfer of FDA, DIN numbers and label parameters from the Inventor to avVaa World Health Care Products, avVaa now owns the exclusive right to manufacture, market, label, distribute and sell its line of proven skin care products throughout the United States and Canada. avVaa products included in the FDA and DIN transfers are: NEUROSKIN Acne Treatment, an acne medication lotion; NEUROSKIN Psoriasis Relief, for seborrheic dermatitis and psoriasis lotion; and NEUROSKIN Itch Relief, a topical analgesic lotion.

For online purchases, go to http://www.neuroskin.com/

  • Rapid Revenue Results. According to Management, the Company's product, NEUROSKIN® Psoriasis Relief has the potential to bring in revenues of over $6.7 Million, with potential projected sales of over $12.7 Million over a 12 month period.
  • Natural & Environmentally Friendly Products. Recent headlines focusing on tests done on two substances, known as D4 and D5, which is found in shampoo, soap, antiperspirant and hundreds of other personal care products, showed they pose a danger to wildlife and aquatic life. There are hundreds of thousands of beauty care products available around the world, most containing damaging chemicals, preservatives and toxins. None of avVaa World Health Care products do not contain the 2 chemicals, known as cycolmethicone exact D4 and D5. The products are all effective, natural, therapeutic skin care products for humans and animals alike.
  • Superior Lead Product. Tests in Germany have proven that the NEUROSKIN product to be effective on 995 out of 1000 people (99.5%). The tests indicated and proved NEUROSKIN did not cause any side effects. Unlike many competitors, NEUROSKIN does not contain cortisone, antibiotics, alcohol, steroids or other unnatural ingredients or additives. The formula is non-greasy and odorless, does not stain clothing, and is easy to use.
  • Huge Market Potential. The United States alone has an estimated market size of 40 million skin disease sufferers and a potential market spending of US $4 Billion. There are 7 million people living in the United States that are affected by some form of psoriasis. Approximately two hundred and fifty thousand new cases are reported each year.
  • Seasoned Management Team. The management team of avVaa World Health Care Products is strong in the sales and marketing with strong emphasis in financial accounting, pharmaceutical and banking experience. The medical research team is comprised of world-renowned medical professionals in the fields of dermatology and radiation oncology.

  Market Potential

  • Seventeen million (17 million) Americans have acne (*The National Institute of Arthritis and Musculoskeletal and Skin Diseases).
  • There are 7 million people living in the United States that are affected by some form of psoriasis. Approximately two hundred and fifty thousand new cases are reported each year. (*Well-Connected Report, 1999 Nidus Information Services Inc., June 1999).
  • "Skin problems are exceedingly common: 30% of Americans have dermatological conditions requiring a physician's care. Moreover, the skin and its appendages (the hair and nails) play a paramount role in our psychological makeup." (*Cecil Textbook of Medicine 20th edition, 1996).
  • Over 16 million people living in the United States are affected by eczema (*The National Institute of Arthritis and Musculoskeletal and Skin Diseases).
  • *Research by the National Psoriasis Association, the USA Dermatologist Association and other institutions indicate that close to $4 billion is spent on treatments for psoriasis, eczema, and acne per year.
  • "85% of the US population between ages 12-25 develops some form of acne." (*FDA Consumer Report, "On the Teen Scene" section of WebMD Health).
  • The psoriasis market is continuing to grow with the aging population and affects between 0.5% - 3% of the world's population, (*Well-Connected Report, 1999 Nidus Information Services Inc., June 1999).
  • *Forrester Research states in their article "B2B Healthcare Spending Shifting Online" (Jan. 2000), "Over-the-counter drugs, health and beauty aids will contribute $1.9 billion and $900 million, respectively, to the online retail category."
  • The market size for the health and natural food store market tops 9,245 stores in USA with sales reaching $14 billion in 2000. (*source: www.marketresearch.com)


Target Markets

Primary Target Markets

  • Individuals suffering with psoriasis, eczema and acne and various other skin diseases;
  • Pharmaceutical Retail outlets;
  • Mainstream and Specialty Drug and Food Chain outlets
  • Institutions - hospitals, clinics, prisons.

Secondary Target Markets

  • Health and Natural Food Store Market.
  • Private brand companies.

The initial focus has been directed on the primary US and Canadian target markets. Entry into Central America, South America and eventual world markets will be next. Distribution and sales agreements have been discussed with several countries to date.

Private branding allows skin care companies such as Avon, Mary Kay, Revlon, etc. to market avVaa products under their specific brand name. This has already been done with VP Plus Marketing and Petonic Pet Supply. NEUROSKIN is registered as FDA compliant, both as a skin care cosmetic and over-the-counter pharmaceutical product, the market appeal for private branding and cosmetic companies is very strong.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#11035   AVVH feed me those 100MM .0001s Lime Time 10/11/19 11:03:19 PM
#11034   Jump from 0001 to 0003 on a 10k stocksmanjr 08/05/19 04:07:06 PM
#11033   $500 betting on this going back to 001 stocksmanjr 07/23/19 07:36:48 PM
#11032   Give me some 1’s Maintenance_Man 06/24/19 10:59:34 AM
#11031   $AVVH: Gobbling up this Perfect SHELL makinezmoney 06/24/19 09:58:41 AM
#11030   Ask dropping, bid building. NITE moved back to OTC-Insider 02/28/19 01:25:51 PM
#11029   https://www.hugedomains.com/domain_profile.cfm?d=avvaa&e=com ed7777777 02/27/19 06:07:27 AM
#11028   NITE @ 4 jindal 01/17/19 03:46:00 PM
#11027   This ran to .0005 last time. There has OTC-Insider 01/17/19 12:55:35 PM
#11026   ETRF Has moved to "5" jindal 01/17/19 10:35:54 AM
#11025   Another 5.29 mil today - someone invested $1,059 stocksmanjr 01/10/19 04:06:17 PM
#11024   Really hope so. Some good activity on this EnggMind 01/10/19 02:01:23 PM
#11023   Continued buying @ 0002. Somebody knows something... stocksmanjr 01/10/19 01:12:02 PM
#11022   50 cent and $5 trades moving this up stocksmanjr 01/04/19 12:35:38 PM
#11021   Jumped to 0003 and settled @ 00025. Amazing stocksmanjr 01/03/19 04:44:06 PM
#11020   No apparent reason but someone spent $15K this week. stocksmanjr 12/28/18 04:22:44 PM
#11019   On close watch. 3’s are ultra thin. When OTC-Insider 12/28/18 01:08:59 PM
#11018   Any reason for the uptick and volume? EnggMind 12/20/18 04:00:20 PM
#11017   NOUV WOW !! TSTS could be another one.. jindal 12/20/18 02:24:26 PM
#11016   Got mine. Let's see what happens from now jindal 12/20/18 02:09:22 PM
#11015   Not going anywhere till my 2 order is jindal 12/20/18 01:59:28 PM
#11014   Let's go baby !!!! jindal 12/20/18 01:49:55 PM
#11013   $AVVH: $0.0002s going fast now... $0.0003 not far off makinezmoney 12/20/18 01:47:05 PM
#11012   $AVVH: Now 400Million Bidding... woah makinezmoney 12/20/18 01:45:37 PM
#11011   $AVVH: 250Million still bidding... the next $NOUV here makinezmoney 12/20/18 01:43:56 PM
#11010   17 million shares today. I don't understand how stocksmanjr 12/14/18 04:48:32 PM
#11009   Pumpers group sold out BuyLowSellHigh 09/24/18 12:11:49 PM
#11008   You may be misinformed about the last AVVH stocksmanjr 09/24/18 09:09:25 AM
#11007   Absolutely would take off on real news - stocksmanjr 09/24/18 09:00:21 AM
#11006   this was good then the CEO sold off RPAB 08/31/18 11:43:42 AM
#11005   Any updates? BuyLowSellHigh 08/24/18 01:30:11 PM
#11004   Will this take off again? On real news BuyLowSellHigh 08/16/18 11:57:50 PM
#11003   ...this thing NEVER has done much....find another 000 ROCKY LEDGE 08/14/18 02:14:28 AM
#11001   it is already dark so the sec cant okwife 08/09/18 12:37:33 PM
#11000   That's probably the likeliest. The question then Slojab 08/09/18 12:28:04 PM
#10999   SELLING THE SHELL to another ? okwife 08/09/18 12:00:55 PM
#10998   Who is the CEO? Slojab 08/09/18 10:54:40 AM
#10997   ....another to just accumulate.....Chickadees say "cheep cheep"!!!! Plant ROCKY LEDGE 08/09/18 10:23:30 AM
#10996   That would be a twist if the NOTICE stocksmanjr 08/08/18 08:06:56 PM
#10995   Don't buy at the ask. Don't buy at stocksmanjr 08/08/18 07:52:19 PM
#10994   The real case is that this has been stocksmanjr 08/08/18 07:48:06 PM
#10993   Well, then I guess it's something you should Slojab 08/08/18 02:59:26 PM
#10992   AVVH that could be fake too. okwife 08/08/18 02:35:11 PM
#10991   This post by nodummy explains it all. Slojab 08/08/18 02:15:00 PM
#10990   AVVH was fake news yesterday or today, which okwife 08/08/18 01:49:54 PM
#10989   I don't know. That 3 year chart Slojab 08/08/18 10:43:04 AM
#10988   The case is that this is historically the Smithers500 08/08/18 10:37:00 AM
#10987   What's the case for buying? Simply because Slojab 08/08/18 10:02:48 AM
#10986   Sellers are gone! Only up from here, buy Smithers500 08/08/18 09:59:52 AM
#10985   Some strong buys in the 3's and perhaps Smithers500 08/08/18 09:09:39 AM